OMICS Group, the world pioneer for organizing 150 International conferences in USA, Europe, Asia and other continents. Uniquely, 350 peer-reviewed open access journals were operating by OMICS Publishing Group. This will reflect the scope in current research and development in science, healthcare and technology. With a strong intention to accelerate the scientific discovery, OMICS Group International has been associated with more than150 scientific Societies and Associations.
OMICS Group refereed journals were well established with more than 30000 Editorial board members. These journals were dedicated to provide significant services for more than 3 million readers across the globe.
With the great success of International conferences-Symposiums, Immunology-2012, Chicago, USA and Immunology Summit-2013, Las Vegas, USA, OMICS Group is proud to organize the 3rd International Conference and Exhibition on Clinical & Cellular Immunology (Immunology Summit-2014) during September 29th-October 01st, 2014 at Baltimore, USA with a theme “From basic immune understanding to clinical breakthroughs”.
Immunology Summit-2014 has been associated with the International Immunomics Society, and AutoImmunity Network. Immunome Research journal is the official co- sponsor. Vaccinogen Inc., a Biotechnology company with more than 3 decades of research and the producer of OncoVAX® is the official event partner to bring together immunologists, academicians, industry researchers and scholars to exchange and share their experiences and research results about all aspects of immunology.
The major sessions includes, Cellular Immunology will hosts original investigations in immunological activities of cells in experimental or clinical situations. Neuro Immunology for combining Neuroscience and Immunology. Autoimmunity session will focus on the process of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic autoantibody tests, and the epidemiology, pathophysiology, and treatment of autoimmune diseases. Auto antibodies and Autoantigens will describes the significance of antibodies. And other sessions like Caner Immunotherapy, and Inflammation. The sessions were designed for presentations to individual interest, but not limited. The intent behind this is to broaden the scope of the meetings by covering new developments.
Cancer and Tumor Immunobiology
Infectious Diseases and Immune System
Autoimmunity and Therapathies
Allergy and Therapathies
T-Cells and B-Cells
Technological Innovations in Immunology
Immunoinformatics and Systems Immunology